Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19.
Koh JY, Ko JH, Lim SY, Bae S, Huh K, Cho SY, Kang CI, Chung DR, Chung CR, Kim SH, Peck KR, Lee JS.
Koh JY, et al. Among authors: cho sy.
Clin Immunol. 2023 Jun;251:109628. doi: 10.1016/j.clim.2023.109628. Epub 2023 Apr 27.
Clin Immunol. 2023.
PMID: 37119951
Free PMC article.